| Pneumonia |
1 |
1 |
| Mechanical Ventilation |
0 |
0.68 |
| Nosocomial Pneumonia |
0 |
0.54 |
| Acinetobacter |
0 |
0.43 |
| Antibiotics |
0 |
0.35 |
| Diarrhea |
0 |
0.35 |
| Hospital-Acquired Infection |
0 |
0.34 |
| Aminotransferase |
0 |
0.32 |
| Otolaryngology |
0 |
0.31 |
| MRSA |
0 |
0.24 |
| Ventilator-Associated Pneumonia |
0 |
0.23 |
| Clinical Guidelines |
0 |
0.22 |
| Hospital |
0 |
0.22 |
| Impairment |
0 |
0.22 |
| Ventilator |
0 |
0.22 |
| Renal Failure |
0 |
0.14 |
| Toxicology |
0 |
0.14 |
| Anemia |
0 |
0.11 |
| Centers for Disease Control and Prevention |
0 |
0.11 |
| Central Nervous System |
0 |
0.11 |
| Escherichia coli |
0 |
0.11 |
| Europe |
0 |
0.11 |
| Health Care Economics |
0 |
0.11 |
| Klebsiella Infections |
0 |
0.11 |
| Microbicides |
0 |
0.11 |
| Nausea |
0 |
0.11 |
| Pseudomonas Aeruginosa Infection |
0 |
0.11 |
| Seizure |
0 |
0.11 |
| Serratia |
0 |
0.11 |
| Staphylococcus Aureus Infection |
0 |
0.11 |
| Stenotrophomonas Maltophilia |
0 |
0.11 |
| Thorax |
0 |
0.11 |
| Tracheostomy |
0 |
0.11 |
| Washington |
0 |
0.11 |
| Atrial Fibrillation |
0 |
0.07 |
| Headache |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |
| Staphylococcal Infection |
0 |
0.07 |